Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HQH
HQH logo

HQH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
17.970
Open
17.860
VWAP
17.78
Vol
94.15K
Mkt Cap
--
Low
17.670
Amount
1.67M
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
abrdn Healthcare Investors (the Fund), formerly Tekla Healthcare Investors, is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.
Show More

Events Timeline

No data

No data

News

NASDAQ.COM
2.0
03-20NASDAQ.COM
Healthcare Stocks Sell Off Amid Middle East Turmoil
  • Reasons for Sell-Off: Healthcare stocks are experiencing a sell-off due to turbulence in the Middle East, despite typically being resilient during global uncertainties; the sector has been weighed down for months by Medicaid cuts and pharmaceutical tariffs, impacting investor confidence.
  • Pfizer's Outlook: Pfizer (PFE) shares are currently worth half of their value from 2021, facing a patent cliff that could affect $17 billion in annual revenue by 2030; while the company is pursuing new drug developments through acquisitions, it still grapples with declining COVID drug sales in the short term.
  • Alexandria Real Estate's Performance: Alexandria Real Estate Equities (ARE) has seen its stock plummet nearly 75% since its 2022 peak, primarily due to rising interest rates and an oversupply of lab space; although it is leasing to tech companies to offset demand issues, it still faces ongoing financial pressures and plans to cut its dividend by 45%.
  • Healthpeak Properties IPO Plans: Healthpeak Properties (DOC) is set to launch an IPO for its senior housing portfolio, which will expose it to greater market risks despite retaining a majority stake; currently, its dividend coverage is slightly above 70%, but the company must demonstrate recovery potential in the life sciences sector.
PRnewswire
8.0
01-12PRnewswire
Aberdeen Investments Funds Declare 2026 Distributions, Up to $0.9060 per Share
  • Distribution Payments: Aberdeen Investments Funds paid distributions on January 12, 2026, to shareholders of record as of December 31, 2025, with the highest being $0.9060 per share for the India Fund (IFN), demonstrating the company's commitment to providing stable returns to investors.
  • Distribution Policy Implementation: All funds have adopted a distribution policy aimed at providing stable payouts from current income and realized capital gains, reflecting the company's robust strategy amid market fluctuations.
  • Shareholder Options: For certain funds, shareholders can choose to receive distributions in cash or newly issued shares, showcasing the company's flexibility in meeting diverse investor needs and enhancing shareholder engagement.
  • Tax Compliance: Under the Investment Company Act of 1940, funds are required to inform shareholders about the sources of distributions, ensuring transparency and compliance, which further strengthens investor trust in the funds.
Newsfilter
8.0
01-12Newsfilter
Aberdeen Investments Funds Announce 2026 Distributions, Up to $0.906 per Share
  • Distribution Payments: Aberdeen Investments Funds paid distributions on January 12, 2026, to shareholders of record as of December 31, 2025, with the abrdn India Fund distributing up to $0.906 per share, reflecting the company's robust income distribution capability.
  • Distribution Policy Implementation: All funds have adopted a stable distribution policy to ensure investors receive consistent payouts from current income, supplemented by realized capital gains, aiming to enhance investor confidence and attract more investments.
  • Transparency of Distribution Sources: In compliance with the Investment Company Act of 1940, the funds are required to inform shareholders about the estimated sources of distributions, thereby improving corporate governance transparency and shareholder trust.
  • Market Performance Impact: The distribution payments may lead to a decrease in net assets, potentially affecting the funds' annual operating expense ratios and market prices, prompting investors to monitor the implications of the distribution policy on market performance.
SeekingAlpha
8.0
2025-11-12SeekingAlpha
abrdn Healthcare Investors announces $0.57 dividend payout
  • Dividend Declaration: abrdn Healthcare Investors (HQH) has announced a quarterly dividend of $0.57 per share, payable on January 12, with shareholders of record on November 21.

  • Ex-Dividend Date: The ex-dividend date for the upcoming dividend is also set for November 21.

  • Performance Rating: HQH has been rated as severely underperforming compared to its peers, leading to a downgrade in its rating.

  • Investment Strategy: The commentary suggests an income approach to capitalize on the healthcare recovery, as indicated in abrdn Healthcare Investors' Q2 2025 commentary.

NASDAQ.COM
8.0
2025-09-18NASDAQ.COM
"12% Dividend Now Available at a Discount Due to a $30 Billion 'Hidden' Strategy"
  • Dividend Opportunity: The article highlights a unique investment opportunity in the UK insurer Phoenix Group, which is pulling GBP22 billion from Aberdeen Group to manage funds in-house, presenting a 12%+ dividend yield in a struggling sector.

  • Aberdeen's Performance Issues: Aberdeen Group has faced poor performance and negative sentiment, particularly with its international closed-end funds, leading to a focus on two specific funds, abrdn Healthcare Investors (HQH) and abrdn Healthcare Opportunities Fund (THQ), which have shown better performance against benchmarks.

  • Investment Potential: HQH is noted for its deeper discount and better-performing portfolio compared to THQ, making it an attractive option for investors seeking dividends and potential capital gains as market sentiment around pharmaceuticals may improve.

  • Monthly Payout Preference: The author expresses a preference for funds that offer monthly payouts, which indicate management confidence, and suggests considering five top monthly dividend closed-end funds with a yield of 10.2% and potential for 20% capital gains.

SeekingAlpha
8.0
2025-08-12SeekingAlpha
abrdn Healthcare Investors declares $0.51 dividend
  • Dividend Announcement: abrdn Healthcare Investors (NYSE: HQH) has declared a quarterly dividend of $0.51 per share, payable on September 30 to shareholders of record as of August 22, with an ex-dividend date also on August 22.

  • Investment Insights: The commentary highlights concerns regarding the high risk and low return associated with HQH's focus on biotech investments, while also noting its efficiency in generating income from healthcare.

Valuation Metrics

The current forward P/E ratio for abrdn Healthcare Investors (HQH.N) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess abrdn Healthcare Investors's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding HQH

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is abrdn Healthcare Investors (HQH) stock price today?

The current price of HQH is 17.69 USD — it has decreased -1.12

What is abrdn Healthcare Investors (HQH)'s business?

abrdn Healthcare Investors (the Fund), formerly Tekla Healthcare Investors, is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.

What is the price predicton of HQH Stock?

Wall Street analysts forecast HQH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HQH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is abrdn Healthcare Investors (HQH)'s revenue for the last quarter?

abrdn Healthcare Investors revenue for the last quarter amounts to NaN USD, decreased

What is abrdn Healthcare Investors (HQH)'s earnings per share (EPS) for the last quarter?

abrdn Healthcare Investors. EPS for the last quarter amounts to USD, decreased

How many employees does abrdn Healthcare Investors (HQH). have?

abrdn Healthcare Investors (HQH) has 0 emplpoyees as of March 22 2026.

What is abrdn Healthcare Investors (HQH) market cap?

Today HQH has the market capitalization of 0.00 USD.